698
Participants
Start Date
February 15, 2024
Primary Completion Date
July 15, 2025
Study Completion Date
July 15, 2025
Level A
Pharmacy personnel will generate a general recommendation based on the AKI KDIGO management guidelines to the physician.
Level B
The pharmacist will make nephrotoxic/renally eliminated medication management recommendations to the attending physician (or designee). Recommendations may include stopping or changing a drug, changing dose or schedule, ordering laboratory tests, taking no action, or other. The pharmacist will record details of the interaction with the physician and whether recommendations were accepted.
Passive Alert
Passive Cerner alert provides decision support within the EMR for the diagnosis and basic staging of AKI but without specific recommendations for management.
UPMC McKeesport, McKeesport
UPMC Magee, Pittsburgh
UPMC Presbyterian/Montefiore, Pittsburgh
UPMC Shadyside, Pittsburgh
UPMC Jameson, New Castle
UPMC Horizon, Farrell
UPMC Altoona, Altoona
UPMC Williamsport, Williamsport
University of Florida
OTHER
University of Pittsburgh Medical Center
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Pittsburgh
OTHER